These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 30401776)

  • 1. Splicing Factor 3B Subunit 1 Interacts with HIV Tat and Plays a Role in Viral Transcription and Reactivation from Latency.
    Kyei GB; Meng S; Ramani R; Niu A; Lagisetti C; Webb TR; Ratner L
    mBio; 2018 Nov; 9(6):. PubMed ID: 30401776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shutdown of HIV-1 Transcription in T Cells by Nullbasic, a Mutant Tat Protein.
    Jin H; Li D; Sivakumaran H; Lor M; Rustanti L; Cloonan N; Wani S; Harrich D
    mBio; 2016 Jul; 7(4):. PubMed ID: 27381288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posttranscriptional Regulation of HIV-1 Gene Expression during Replication and Reactivation from Latency by Nuclear Matrix Protein MATR3.
    Sarracino A; Gharu L; Kula A; Pasternak AO; Avettand-Fenoel V; Rouzioux C; Bardina M; De Wit S; Benkirane M; Berkhout B; Van Lint C; Marcello A
    mBio; 2018 Nov; 9(6):. PubMed ID: 30425153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long Noncoding RNA uc002yug.2 Activates HIV-1 Latency through Regulation of mRNA Levels of Various RUNX1 Isoforms and Increased Tat Expression.
    Huan C; Li Z; Ning S; Wang H; Yu XF; Zhang W
    J Virol; 2018 May; 92(9):. PubMed ID: 29491162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency.
    Mousseau G; Kessing CF; Fromentin R; Trautmann L; Chomont N; Valente ST
    mBio; 2015 Jul; 6(4):e00465. PubMed ID: 26152583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV latency reversing agents act through Tat post translational modifications.
    Khoury G; Mota TM; Li S; Tumpach C; Lee MY; Jacobson J; Harty L; Anderson JL; Lewin SR; Purcell DFJ
    Retrovirology; 2018 May; 15(1):36. PubMed ID: 29751762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism.
    Boehm D; Calvanese V; Dar RD; Xing S; Schroeder S; Martins L; Aull K; Li PC; Planelles V; Bradner JE; Zhou MM; Siliciano RF; Weinberger L; Verdin E; Ott M
    Cell Cycle; 2013 Feb; 12(3):452-62. PubMed ID: 23255218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SAMHD1 Impairs HIV-1 Gene Expression and Negatively Modulates Reactivation of Viral Latency in CD4
    Antonucci JM; Kim SH; St Gelais C; Bonifati S; Li TW; Buzovetsky O; Knecht KM; Duchon AA; Xiong Y; Musier-Forsyth K; Wu L
    J Virol; 2018 Aug; 92(15):. PubMed ID: 29793958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Molecular Basis for Human Immunodeficiency Virus Latency.
    Mbonye U; Karn J
    Annu Rev Virol; 2017 Sep; 4(1):261-285. PubMed ID: 28715973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UHRF1 Suppresses HIV-1 Transcription and Promotes HIV-1 Latency by Competing with p-TEFb for Ubiquitination-Proteasomal Degradation of Tat.
    Liang T; Zhang Q; Wu Z; Chen P; Huang Y; Liu S; Li L
    mBio; 2021 Aug; 12(4):e0162521. PubMed ID: 34465029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Stronger Transcription Regulatory Circuit of HIV-1C Drives the Rapid Establishment of Latency with Implications for the Direct Involvement of Tat.
    Chakraborty S; Kabi M; Ranga U
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32669338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA-induced epigenetic silencing inhibits HIV-1 reactivation from latency.
    Méndez C; Ledger S; Petoumenos K; Ahlenstiel C; Kelleher AD
    Retrovirology; 2018 Oct; 15(1):67. PubMed ID: 30286764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NUCKS1, a novel Tat coactivator, plays a crucial role in HIV-1 replication by increasing Tat-mediated viral transcription on the HIV-1 LTR promoter.
    Kim HY; Choi BS; Kim SS; Roh TY; Park J; Yoon CH
    Retrovirology; 2014 Aug; 11():67. PubMed ID: 25116364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HEXIM1-Tat chimera inhibits HIV-1 replication.
    Leoz M; Kukanja P; Luo Z; Huang F; Cary DC; Peterlin BM; Fujinaga K
    PLoS Pathog; 2018 Nov; 14(11):e1007402. PubMed ID: 30395647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitotic deacetylase complex (MiDAC) recognizes the HIV-1 core promoter to control activated viral gene expression.
    Wilhelm E; Poirier M; Da Rocha M; Bédard M; McDonald PP; Lavigne P; Hunter CL; Bell B
    PLoS Pathog; 2024 May; 20(5):e1011821. PubMed ID: 38781120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic Chromatin-Modifying Treatments Reactivate Latent HIV and Decrease Migration of Multiple Host-Cell Types.
    Blanco A; Mahajan T; Coronado RA; Ma K; Demma DR; Dar RD
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34201394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV Silencing and Inducibility Are Heterogeneous and Are Affected by Factors Intrinsic to the Virus.
    Norton NJ; Mok HP; Sharif F; Hirst JC; Lever AML
    mBio; 2019 Jun; 10(3):. PubMed ID: 31239371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of HIV-1 Tat-Associated Proteins Contributing to HIV-1 Transcription and Latency.
    Jean MJ; Power D; Kong W; Huang H; Santoso N; Zhu J
    Viruses; 2017 Apr; 9(4):. PubMed ID: 28368303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fused in sarcoma silences HIV gene transcription and maintains viral latency through suppressing AFF4 gene activation.
    Krasnopolsky S; Marom L; Victor RA; Kuzmina A; Schwartz JC; Fujinaga K; Taube R
    Retrovirology; 2019 Jun; 16(1):16. PubMed ID: 31238957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Viral latency of HIV-1].
    Bouchat S; Van Lint C
    Virologie (Montrouge); 2019 Aug; 23(4):195-210. PubMed ID: 31414658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.